The Study
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
This study is like taking a snapshot of where a certain protein (GLP-1 receptor) shows up in different human tissues and tumors. It can tell us where it is found, but not whether targeting it will actually help treat cancer or work in real patients.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
Scientists looked at where GLP-1 receptors are located in human body tissues and tumors to see if they can be used to take pictures of tumors or treat them with radiation.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 535 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This means doctors might be able to use these receptors to find or treat certain tumors without harming healthy parts of the body.
- 2Receptors were found in 419 tumors and 209 normal tissue samples.
- 3High levels were seen in pheochromocytomas, brain tumors, and embryonic tumors.
- 4No receptors were found in carcinomas, lymphomas, liver, spleen, lymph nodes, or adrenal glands.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of Nuclear Medicine
Year
2007
Authors
M. Körner, M. Stöckli, B. Waser, J. Reubi
Related Content
Claims (5)
Your body has special switches called GLP-1 receptors not just in your gut and pancreas, but also in your heart, brain, kidneys, and even cartilage — and they help control different body functions in all those places.
Some tumors have a special marker that might let doctors see them better on scans or treat them with targeted radiation, because the marker shows up strongly on the tumor but not in healthy tissue around it.
Some tumors have a special 'door' called GLP-1 receptors that other cancers don’t have — this might let doctors target just those tumors without affecting healthy cells.
GLP-1 receptors are found in small amounts in certain parts of healthy human organs like the pancreas, gut, lungs, and brain, but they’re not found at all in the liver, spleen, lymph nodes, or adrenal glands.
Scientists used a labeled version of a hormone to see where it sticks in human tissues, and the pattern they found confirms it’s attaching to specific receptors linked to GLP-1 — in both healthy and tumor tissues.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.